Member Info for CHELSEA7

Just rethinking my wordings lol, yes I agree with that. Using IMHO and providing links backing up statements are always beneficial.

Well have a good day guys
Best wishes to all.

Think that is for each to decide. My take on criticism is that it should be constructive and not sure any of us know better than the bod in the science to achieve that

Yeah very good post, still waiting to hear Agm and a few links, find the phone hard going.

The potential is enormous as I posted last week just three Mabs, tcr or glycans deals at l£ 10mp.a gives us £30m a year income.

Let's get all the sciences right as Ray says first the rewards are enormous

Agree with that totally Ray, it is not opinions that bother me, it is the concept that we know better, despite nor knowing the realities of all that goes on. I do believe in Lindy and B.o.d

Morning guys, WTP "nice 2nd post"!! Lol. Saves commenting on.

Still waiting on my computer £200 for a new hard drive, working great and an hour later a keyboard covered in diet coke. Another £230 might be back today, but at least they delivered my new phone 3rd time of asking. Cant bear using it as a computer though.

Just to let you know knowlesi mailed me just before my computer drowned. A very welcome mail, we were truly fed up with the rows on this Bb. It's why I have been avoiding it really, it was getting me down. We had been in contact before but there is one row well over. Whether right or wrong we both respected where we were coming from as people rather than posters. My respect to Knowlesi, very kind thoughts from him , returned and hope we can all lift that sentiment too. I doubt many have enjoyed it and it is today that matters. Have a good one.

Thanks Ray, well I think the majority of us are astounded by what we have achieved on our resources, when we consider scancell now to the one which gained admittance to Aim there is no comparison. Growth has been achieved on a micro budget and money doesn't buy science but scients do and can speed up the enormous work involved in the finishing article. There were a few negative cries as to our wage bill, it is from my experiences in business easy to employ people far more tricky to get the right ones...so funding is very important to avoid delays and get new platforms Tcr ready for commercial activity. We are getting there imho and just thrilled vulpes can help in such an important area. Atb

Yes I understand the direction you were taking Ray, we have read much about bioNtec an Moderna and thus funding between us and them is staggering low, and just wondered how vulpes would re igornaisee that issue over the next few months?

Afternoon Ray, amazing they are so many years away from their first coMmercial product. And still with $450k expenditure and $100m a year R & D costs for the next five years. Let's see how Vulpes can get us anywhere near to those resources

Well done passing 30k posts, hugely appreciated (mostly, lol) thanks. Catch her tomorrow interesting posts today

C

Agree inanaco, I believe it was ivy himself clamouring for a vociferous agm for that very reason. I think we can all see many exciting possibilities here, trouble with giving an opinion is we leave yourself open to criticism 0and charges of ramping. FWIW Dracula no one is on 0a high horse, anything is possible, let's see how the news goes for a clearer guide. Certainly good to see healthy debate, not sure what you mean when you say some here, you were only asked a question about where 2023 came from, I had missed that. Bermuda answered for you nobody was having the slightest dig at you, at all. We and scooby do apologised to one another more than once for any left overs from the VAL BB, confused what has changed

Indeed it is. Fascinating possibilities though.Have a good day

Inanaco, when you s0ay defined groups c0an you see scib1 used in combo with new peptides?

Great post. Well I refer again to Vulpes, boy did they research us, five years worth and extensive due diligence. Possibilities seem endless imho

Was thinking the same thing crumbs. They said they could be used as a combo therapy so does that include scibs and mod? I would have thought so, which makes things interesting

Very true miavoce, and we see the arms scenario possibly at play. I have always seen the appointment of Samantha Paston from adaptimmune as a major pre cursor to new platforms and deals much like her work at adaptimmune, so yes looking forward to new announcements hopefully in quick succession. Imagine if each Mab produced an income of £10m per year and we had three running? It would pay for three years expenditure and a couple of trials just from income received from one platform. Current M/Cap £34m

Well again we wont get news unless a collaboration is extended, a deal or just one those two interested is the collaborator now. Frustrating but that's how it is

Thanks. Well a one year plan fits into funding ok till 2021

I haven't listened to the recording yet, waiting for my computer to come back from hospital. What was said about our collaboration on the third platform?

Reason I mentioned traditional aim funding is because vulpes will know many better ways to fund like loan agreements etc. Just a big plus for us to have them on our BOD. Chances of a deal in our third platform look pretty encouraging to me.

Indeed, never did understand some of the negative spins going on re Vulpes investment. I remember Ruck saying to me it would be wrong to presume they were our Messiah, but that wasn't being negative just a reminder to see what happens. Fair enough. But as he said and reiterated he is here for the long term. It could well mean we will not have to have any more traditional AIM placing. I mentioned last week we would have a cash flow exceeding £7m based on 450k a month expenditure since May, which was rather born out by the bod confirming we were good to early 2021, and with the "six month" timeline given and presuming first results from Scib 1 will be with us by then yes I am very excited. Feeling very confident my sub 15p average will be passed, so holding tight for now